AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Abroad (travel likely)RecruitingPHASE1

Conditions

Follicular Lymphoma · Mantle Cell Lymphoma · Hairy Cell Leukemia · Lymphoplasmacytic Lymphoma · Burkitt Lymphoma · Marginal Zone Lymphoma · Waldenstrom Macroglobulinemia · Large B-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Stanford University, Palo Alto, California, United States
Contact: Study coordinator (Kelly Chyan) · kchyan@stanford.edu · 650-625-8130
Contact: Principal Investigator (Matthew Frank, MD)

Study leads

Matthew Frank, MD, PhD
Principal Investigator
Stanford University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Follicular Lymphoma · Lymphoma

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States · Basking Ridge, United States

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Lymphoma · Waldenström Macroglobulinemia (WM) · DLBCL - Diffuse Large B Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Richmond, Australia · Nedlands, Australia

SynKIR-310 for Relapsed/Refractory B-NHL

B Cell Lymphoma · NHL, Adult · Mantle Cell Lymphoma

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Atlanta, United States

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Waldenstrom Macroglobulinemia (WM)

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Orange, United States